| Active Pharmaceutical Ingredients (APIs) | Bulk drug APIs in antibiotics, anti-TB, anti-malarial, corticosteroids, and anti-diabetic categories | Regulatory certifications (WHO, EDQM, USFDA), backward integration, long-standing customer relationships, and diversified markets | Pharmaceutical companies across regulated and semi-regulated markets globally | Specialized APIs with regulatory certifications command higher margins | 661 | 100 | Sales through contracts and export orders to pharmaceutical manufacturers (B2B) | Direct sales based on volume contracts and long-term supply agreements | Increasing global demand, regulatory approvals, capacity expansions, and new product launches | Erythromycin salts, Pyrazinamide, Sulfadoxine, Ambroxol HCL, Gliclazide |
